ELLINGTON MANAGEMENT GROUP LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$192,000
-28.9%
12,800
-58.3%
0.03%
-15.4%
Q2 2017$270,000
+280.3%
30,700
+124.1%
0.04%
+1850.0%
Q1 2017$71,000
-10.1%
13,700
-19.4%
0.00%
-90.9%
Q3 2016$79,000
-9.2%
17,000
+12.6%
0.02%
-81.8%
Q2 2016$87,000
-63.0%
15,100
-61.2%
0.12%
+19.8%
Q1 2016$235,000
-67.4%
38,900
-15.3%
0.10%
-32.2%
Q1 2015$720,000
+27.4%
45,900
+24.1%
0.15%
-43.6%
Q2 2014$565,00037,0000.26%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders